Johnson & Johnson's recent experience shows how uncertain product liability litigation is for drug makers. After winning jury verdicts in three Xarelto (rivaroxaban) bellwether trials, the company was hit with a $417m verdict in a talcum powder lawsuit last month.
Despite the divergent outcomes in personal injury complaints for J&J, pharma companies are seeing some positive trends. One significant development...





